SEMANEO 0.25mg Injection Pen

SEMANEO 0.25mg Injection Pen

Prescription drug
Manufacturer / Marketer : ETABX
Expiry : 31-03-2028
AboutSEMANEO 0.25mg Injection Pen contains Semaglutide, a GLP-1 receptor agonist for Type 2 diabetes and weight management.Usage Instructions: Inject subcutaneously once weekly as directed. Rotate injection sites (abdomen, thigh, upper arm). Follow pen instructions carefully.Benefits: Improves blood sugar control, promotes weight loss, reduces cardiovascular risk, enhances insulin secretion, suppresses appetite.How it Works: Semaglutide mimics GLP-1 hormone, stimulating insulin release, suppressing glucagon, slowing gastric emptying, and reducing appetite.Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, injection site reactions.Safety Advice: Not for Type 1 diabetes or diabetic ketoacidosis. Inform doctor of thyroid cancer history, pancreatitis, or kidney disease. May cause thyroid C-cell tumors in rodents. Monitor for pancreatitis symptoms.Storage: Store refrigerated between 2-8°C. Do not freeze. After first use, may store at room temperature up to 30°C for 6 weeks. Keep pen cap on when not in use.
₹1,139.05 MRP: ₹1,199.00 Save ₹59.95 (5%)
Inclusive of all taxes
Quantity

Expiry Icon
Fresh Stock
Guaranteed
Return Icon
Secure & Hygienic
Packaging
Authentic Icon
Verified & Trusted
Supplements
Quality Icon
Secure
Payment
AboutSEMANEO 0.25mg Injection Pen contains Semaglutide, a GLP-1 receptor agonist for Type 2 diabetes and weight management.Usage Instructions: Inject subcutaneously once weekly as directed. Rotate injection sites (abdomen, thigh, upper arm). Follow pen instructions carefully.Benefits: Improves blood sugar control, promotes weight loss, reduces cardiovascular risk, enhances insulin secretion, suppresses appetite.How it Works: Semaglutide mimics GLP-1 hormone, stimulating insulin release, suppressing glucagon, slowing gastric emptying, and reducing appetite.Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, injection site reactions.Safety Advice: Not for Type 1 diabetes or diabetic ketoacidosis. Inform doctor of thyroid cancer history, pancreatitis, or kidney disease. May cause thyroid C-cell tumors in rodents. Monitor for pancreatitis symptoms.Storage: Store refrigerated between 2-8°C. Do not freeze. After first use, may store at room temperature up to 30°C for 6 weeks. Keep pen cap on when not in use.

Related Products